More about Aster DM Healthcare Limited
Fundamentals for Aster DM Healthcare Limited
Regulatory Filings for Aster DM Healthcare Limited
Defence Profits Reach Dharavi's Machinists
From COVID Debt to Green Despair: Industrial Discharge Is Destroying India’s Last Prawn Nurseries
The Hidden Cost of India's Electronics Assembly Push: A 40% E-Waste Surge and the Death of Affordable Repair
The Wedding Loan Trap: How India’s Microfinance Boom Turned Housewives Into Ghost Borrowers and Temple Brass Into EMI Cash
Fundamentals for Aster DM Healthcare Limited
Business Operations:
Sector: HealthcareIndustry: Medical Care Facilities
Aster DM Healthcare Limited, together with its subsidiaries, provides healthcare and allied services in India, the United Arab Emirates, Qatar, Oman, Kingdom of Saudi Arabia, Jordan, Kuwait and Bahrain, and Republic of Mauritius. It operates through Hospitals, Clinics, Retail Pharmacies, and Others segments. The company operates hospitals and in-house pharmacies at the hospitals; and clinics and in-house pharmacies at the clinics, as well as retail and online pharmacies and optical outlets. It also offers healthcare consultancy and other services. Aster DM Healthcare Limited was founded in 1987 and is headquartered in Dubai, United Arab Emirates.
Revenue projections:
Investors may be wary of ASTERDM as its revenues are expected to fall below the prior year's levels. A revenue decrease often leads to concerns about profitability, as it is likely to affect the company's bottom line, prompting investors to take a more cautious approach.
Financial Ratios:
| currentRatio | 0.000000 |
|---|---|
| forwardPE | 58.916668 |
| debtToEquity | 43.791000 |
| earningsGrowth | -0.105000 |
| revenueGrowth | 0.130000 |
| grossMargins | 0.558480 |
| operatingMargins | 0.121090 |
| trailingEps | 6.380000 |
| forwardEps | 12.000000 |
ASTERDM's high forward PE ratio signals potential overvaluation, limiting further price gains and increasing the risk of a correction. This metric should be carefully considered alongside other key fundamentals to assess the stock's future performance.
ASTERDM's low growth in both earnings and revenue indicates potential profit shrinkage. This downward trend could be a sign of weakening financial health, signaling challenges for the company's future profitability.
Aster DM Healthcare Limited's negative gross and operating margins indicate that the company is not generating profit from either production or day-to-day operations. This could suggest cost overruns or declining revenue, impacting its financial stability.
ASTERDM's forward EPS surpassing its trailing EPS signals that the company is anticipated to be more profitable this year than last. This growth expectation highlights ASTERDM's potential for increased earnings and a stronger financial performance in the upcoming year.
Price projections:
ASTERDM's price has consistently remained near the lower edge of projections, suggesting that it is not fully meeting market expectations. This could indicate a need for improved performance or strategies to boost investor confidence.
Recommendation changes over time:
ASTERDM has received a favorable buy bias from analysts recently, positioning it as a solid investment opportunity. This sentiment may attract more investors, who view ASTERDM as a stable option to park their money and potentially benefit from the company's continued growth and profitability.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
From Lifesaving Drugs to Sick Units: The Hidden Energy Crisis Inside India’s Pharma Clusters
From Price Pressures to Profit Power: The MSME Playbook Redefining India’s Economy
₹90 Crore Bet Signals a Massive Shift in India’s Rural Economy